Author: Michael E. Schatman
A culture of "neuromysticism" has arisen around medical marijuana, breeding confusion for patients and clinicians alike. The dearth of quality research on safety and efficacy is a significant contributor to the situation. Dr. Schatman talks about what we know, what we don't, and where cannabinoids may fit in the pain management armamentarium.
Posted on February 8, 2018